STOCKWATCH

Panacea Biotec Secures INR 127.20 Crore Bivalent Oral Polio Vaccine Supply Contract from CMSS, India

Panacea Biotec Ltd has been awarded a contract by the Central Medical Services Society (CMSS), Ministry of Health and Family Welfare, Government of India for the supply of bivalent oral polio vaccine (bOPV) worth INR 127.20 Crore. The supply will be executed in several tranches over a period of 90 - 480 days from the date of issuance of the Letter of Acceptance (LOA) dated October 08, 2025.

• Panacea Biotec secures INR 127.20 Crore bOPV supply contract from CMSS, India.
• The contract involves supplying bOPV to CMSS in several tranches over 90 - 480 days from the LOA date.
• This deal strengthens Panacea Biotec's presence in the vaccine market and contributes to public health in India.
• The contract is awarded by a domestic entity, the Central Medical Services Society (CMSS), Ministry of Health and Family Welfare, Government of India.
• The supply is worth approximately INR 127.20 Crore (INR 1,272,000,000.00)